Table 1.
Analyses exploring the potential impact of changes in antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) coverage on achieving the “Ending the HIV Epidemic” goals.
Table 2.
Reductions in new HIV infections associated with universal increases to viral suppression through increased antiretroviral therapy (ART) coverage and HIV acquisition reduction through pre-exposure prophylaxis (PrEP) uptake by adults and adults and adolescents in combination.
Fig 1.
The annual HIV incidence per 100,000 population ages 15 to 65 when antiretroviral therapy coverage is 70% and pre-exposure prophylaxis coverage is 20% with and without adolescents ages 15 through 17 included in the uptake of pre-exposure prophylaxis and the annual HIV incidence per 100,000 population ages 15 to 65 when antiretroviral therapy coverage is 90% and pre-exposure prophylaxis coverage is 40% with and without adolescents ages 15 through 17 included in the uptake of pre-exposure prophylaxis.
Table 3.
Reductions in the HIV incidence rate among adolescents ages 15–17 years associated with universal increases to viral suppression through increased antiretroviral therapy (ART) coverage and HIV acquisition reduction through pre-exposure prophylaxis (PrEP) uptake among adults and among adults and adolescents in combination.